Smooth muscle apoptosis and vascular remodeling

Current Opinion in Hematology

Volumn 15, Issue 3, 2008, Pages 250-254

  Korshunov, Vyacheslav A ^a,b   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Vascular remodeling; Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHEMOKINE; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; MYOSIN HEAVY CHAIN; PROTEIN SUBUNIT; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

ANTIHYPERTENSIVE THERAPY; APOPTOSIS; BLOOD PRESSURE; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; ESSENTIAL HYPERTENSION; GENETIC DISORDER; HEMODYNAMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGERIA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; ARTERIES; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 41949140525     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282f97d71     Document Type: Review

References (60)

1. Poelmann RE, Gittenberger-de Groot AC. Apoptosis as an instrument in cardiovascular development. Birth Defects Res C Embryo Today 2005; 75:305-313.
2. Clarke M, Bennett M, Littlewood T. Cell death in the cardiovascular system. Heart 2007; 93:659-664.
3. Thorball N, Moe H, Winther-Nielsen H. Progressive involution and physiological death of smooth muscle cells of rat incisal arterioles. Blood Vessels 1985; 22:157-169.
4. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 1995; 76:168-175.
5. Bochaton P-ML, Gabbiani F, Redard M, et al. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146:1059-1064.
6. Hamet P, Richard L, Dam TV, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26:642-648.
7. Lopez-Candales A, Holmes DR, Liao S, et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997; 150:993-1007.
8. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95:2266-2274.
9. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 2005; 25:2255-2264.
10. Schrijvers DM, De Meyer GR, Herman AG, Martinet W. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007; 73:470-480.
11. Varga R, Eriksson M, Erdos MR, et al. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2006; 103:3250-3255.
12. Kavurma MM, Bhindi R, Lowe HC, et al. Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemost 2005; 3:465-472.
13. Moran EP, Agrawal DK. Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis. Exp Mol Pathol 2007; 83:11-16. Observational clinical study suggested that patients with asymptomatic atherosclerotic plaques have lower expression of antiapoptotic proteins compared with symptomatic patients. This study is in agreement with the current concept that apoptosis is dangerous in advanced atherosclerosis (e.g. references [9,10,14]).
14. Hassan AH, Lang IM, Ignatescu M, et al. Increased intimal apoptosis in coronary atherosclerotic vessel segments lacking compensatory enlargement. J Am Coll Cardiol 2001; 38:1333-1339.
15. Harris LK, Keogh RJ, Wareing M, et al. Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism. Am J Pathol 2006; 169:1863-1874.
16. Keogh RJ, Harris LK, Freeman A, et al. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death. Circ Res 2007; 100:834-841. VSMC apoptosis induced by TRAIL through TRAIL-1,2 receptors provide novel insights into mechanisms by which invading trophoblasts regulate uterine spiral artery remodeling during pregnancy.
17. von Wnuck Lipinski K, Keul P, Lucke S, et al. Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells. Cardiovasc Res 2006; 69:697-705.
18. von Wnuck Lipinski K, Keul P, Ferri N, et al. Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circ Res 2006; 98:1490-1497.
19. Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG. Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis 2006; 188:221-230.
20. Kunz J. Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 2007; 53:63-73.
21. Yang G, Wu L, Wang R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 2006; 20:553-555.
22. Wang X, Li Q, Adhikari N, Hall JL. A role for muscle LIM protein (MLP) in vascular remodeling. J Mol Cell Cardiol 2006; 40:503-509.
23. Daniel S, Patel VI, Shrikhande GV, et al. The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Transplant Proc 2006; 38:3225-3227.
24. Patel VI, Daniel S, Longo CR, et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J 2006; 20:1418-1430.
25. Suzuki J, Jin ZG, Meoli DF, et al. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006; 98:811-817.
26. Nakamura Y, Suzuki S, Suzuki T, et al. MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling. Am J Pathol 2006; 169:362-371.
27. Schwartz SM, Majesky MW, Murry CE. The intima: development and monoclonal responses to injury. Atherosclerosis 1995; 118 (Suppl):S125-S140.
28. Thaunat O, Louedec L, Dai J, et al. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:2359-2365.
29. Clarke MC, Figg N, Maguire JJ, et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006; 12:1075-1080.
30. Nataatmadja M, West J, West M. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 2006; 114:I371-I377.
31. Capell BC, Collins FS, Nabel EG. Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res 2007; 101:13-26. A comprehensive review of human genetic disorders associated with accelerated aging in perspective of new insights into the mechanisms of cardiovascular diseases.
32. Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. Arterioscler Thromb Vasc Biol 2007; 27:1722-1728. In a recent review we have discussed the importance of hemodynamic forces for normal remodeling in conduit artery.
33. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res 1997; 81:328-337.
34. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997; 17:2238-2244.
35. Buus CL, Pourageaud F, Fazzi GE, et al. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 2001; 89:180-186.
36. Sata M, Walsh K. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels. J Mol Cell Cardiol 2000; 32:1395-1400.
37. Kraemer R. Reduced apoptosis and increased lesion development in the flow-restricted carotid artery of p75(NTR)-null mutant mice. Circ Res 2002; 91:494-500.
38. Erami C, Zhang H, Tanoue A, et al. Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol 2005; 289:H744-753.
39. Melaragno MG, Wuthrich DA, Poppa V, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 1998; 83:697-704.
40. Konishi A, Aizawa T, Mohan A, et al. Hydrogen peroxide activates the gas6-axl pathway in vascular smooth muscle cells. J Biol Chem 2004; 279:28766-28770.
41. Korshunov VA, Mohan AM, Georger MA, Berk BC. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006; 98:1446-1452.
42. Torella D, Leosco D, Indolfi C, et al. Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol 2004; 287:H2850-H2860.
43. Korshunov VA, Nikonenko TA, Tkachuk VA, et al. Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. Arterioscler Thromb Vasc Biol 2006; 26:295-300.
44. Chen Z, Sakuma M, Zago AC, et al. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24:709-714.
45. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007; 97:730-737.
46. Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech 2007; 40:947-960.
47. Vouyouka AG, Jiang Y, Rastogi R, Basson MD. Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase- and protein kinase C-dependent manner. J Vasc Surg 2006; 44:1076-1084.
48. Morrow D, Sweeney C, Birney YA, et al. Biomechanical regulation of hedgehog signaling in vascular smooth muscle cells in vitro and in vivo. Am J Physiol Cell Physiol 2007; 292:C488-C496. Pulsatile flow significantly increased VSMC apoptosis both in vitro and in vivo, which was associated with diminished Hedgehog signaling.
49. Sedding DG, Homann M, Seay U, et al. Calpain counteracts mechanosensitive apoptosis of vascular smooth muscle cells in vitro and in vivo. FASEB J 2008; 22:579-589. Cystein protease calpain counteract mechanically induced VSMC apoptosis via its p53-degrading effects in vitro and in vivo.
50. Cheng J, Zhang J, Merched A, et al. Mechanical stretch inhibits oxidized low density lipoprotein-induced apoptosis in vascular smooth muscle cells by upregulating integrin {alpha}Vbeta3 and stablization of PINCH-1. J Biol Chem 2007; 282:34268-34275. Authors provided evidence that mechanical stretch acts as a prosurvival factor for VSMC by upregulation of integrin (αVβ3) and stabilization of PINCH-1, which counteracts ox-LDL.
51. Deblois D, Tea BS, Beaudry D, Hamet P. Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage. Can J Physiol Pharmacol 2005; 83:29-41.
52. Hamet P, Moreau P, Dam TV, et al. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. J Hypertens Suppl 1996; 14:S65-S70.
53. deBlois D, Tea BS, Than VD, et al. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997; 29:340-349.
54. Sharifi AM, Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens 1998; 11:1108-1116.
55. Marchand EL, Der Sarkissian S, Hamet P, deBlois D. Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats. Circ Res 2003; 92:777-784.
56. Gurbanov E, Shiliang X. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg 2006; 30:499-507.
57. Suzuki YJ, Nagase H, Wong CM, et al. Regulation of Bcl-xL expression in lung vascular smooth muscle. Am J Respir Cell Mol Biol 2007; 36:678-687. A transcription factor GATA-4 is important for regulation of antiapoptotic bcl-x(L) gene expression in lung VSMC.
58. Ruiz E, Gordillo-Moscoso A, Padilla E, et al. Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high Bcl-2 expression. Diabetes 2006; 55:1243-1251.
59. Ruiz E, Redondo S, Gordillo-Moscoso A, Tejerina T. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway. J Pharmacol Exp Ther 2007; 321:431-438. Stimulators of PPAR-γ may also induce therapeutic apoptosis through Smad2 in VSMC from diabetic patients.
60. Korshunov VA, Daul M, Massett MP, Berk BC. Axl mediates vascular remodeling induced by deoxycorticosterone acetate salt hypertension. Hypertension 2007; 50:1057-1062. Recent studies in rat genetic model of salt-induced hypertension identified antiapoptotic Axl as a novel candidate gene. Our recent findings strengthen the role of Axl in salt-dependent hypertension and further support that inhibition of vascular antiapoptosis pathways is beneficial in hypertension.